CompletedNCT03575403
Alcohol Effects During Duloxetine and Methylphenidate Treatment
About this title
Read the official source — NCT03575403Medication studyAges 21–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 55 years.
- Listed locations
- LexingtonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: September 1, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 19
- Sponsor
- Craig Rush
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT03575403
- Official title
Show the full official title
A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Craig Rush.
Did this study involve medication?
Yes. The study involved medication, including Alcohol, Placebos, Duloxetine (60 MG), Methylphenidate and Duloxetine (30 MG).
Who was this study for?
Listed age limits: 21 years to 55 years.
